ACCESS AFP ALPHA-FETOPROTEIN 33210

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-11-12 for ACCESS AFP ALPHA-FETOPROTEIN 33210 manufactured by Beckman Coulter.

Event Text Entries

[126896232] The patients? Demographics such as age, date of birth, sex, weight, ethnicity and race were not supplied. The lot number of the reagent was not provided. Information on the expiration date, date of manufacture and udi cannot be determined. The access afp reagent was not returned for evaluation. The customer reported that quality control, calibration and system check were all performing within specifications. The access afp results of other samples and the results of all other tests were transmitted and received by the lis correctly. There were no hardware errors or issues with other results reported in conjunction with this event. The beckman coulter field service engineer (fse) and laboratory system support (lss) dispatched to the customer's site did not identify any hardware, software, reagent or system issues that would have contributed to this event. The fse was unable to reproduce this event. Re-transmission of the initial access afp result was sent and received with no errors. The cause of this isolated event cannot be determined.
Patient Sequence No: 1, Text Type: N, H10


[126896233] The customer contacted beckman coulter on (b)(6) 2018 to report elevated alpha-fetoprotein (access afp) results for one patient sample. The result was generated on the laboratory's unicel dxi 800 access immunoassay system (serial number (b)(4)) and recovered at 3. 45 ng/ml. The customer? S reference range is 0. 0? 13. 4 ng/ml. The customer? S laboratory information system (lis) recorded an elevated result of 345 ng/ml. The elevated access afp result was released from the lis and the report was sent to the patient. There was a change in patient care attributable to the elevated access afp result as the patient was admitted to a hospital and received treatment. The details of the treatment were not provided. The results of the testing in the hospital were reported to be normal. The customer did not report any additional change or impact to patient care or treatment in association with this event. The customer reported that quality control (qc), calibration and system check were performing within assay and instrument specifications at the time of the event. Information on the collection and processing of the patient sample is not available. No issues with sample integrity were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2122870-2018-01031
MDR Report Key8060137
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-11-12
Date of Report2018-11-12
Date of Event2018-09-15
Date Facility Aware2018-10-19
Date Mfgr Received2018-10-19
Date Added to Maude2018-11-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. DAVID DAVIS
Manufacturer Street250 S. KRAEMER BLVD.
Manufacturer CityBREA CA 92821
Manufacturer CountryUS
Manufacturer Postal92821
Manufacturer Phone7149613796
Manufacturer G1BECKMAN COULTER
Manufacturer Street1000 LAKE HAZELTINE DRIVE
Manufacturer CityCHASKA MN 55318
Manufacturer CountryUS
Manufacturer Postal Code55318
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameACCESS AFP ALPHA-FETOPROTEIN
Generic NameKIT, TEST,ALPHA-FETOPROTEIN FOR TESTICULAR CANCER
Product CodeLOJ
Date Received2018-11-12
Catalog Number33210
Lot NumberNOT PROVIDED
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBECKMAN COULTER
Manufacturer Address1000 LAKE HAZELTINE DRIVE CHASKA MN 55318 US 55318


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-11-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.